NCAM1 and graft versus host disease: From a diagnostic perspective, receiver operating characteristic curve analysis demonstrated that a CD56+:CD3+ ratio below 11% had high sensitivity and specificity for the diagnosis of GVHD, suggesting that quantification of these cells in intestinal mucosa could serve as a useful biomarker.